Autopsy report · NCT02949908

MEasuring Satisfaction of Treatment With REbif After Initial Treatment of Multiple Sclerosis (MS)

Cause of deathOther Automatic label, confidence 0.3, unverified. How labels are made.

“Delay in site selection and recruitment.”

The sponsor’s own words in the registry.

Life of this trial

Registered 4 months before it started.
Ran for about 7 months before it stopped.
2 participants enrolled.
Results were posted on the registry 1 year 5 months after it ended.

Vital statistics

Status: Terminated
Sponsor: Merck KGaA, Darmstadt, Germany
Sponsor type: Industry
Conditions: Multiple Sclerosis
Interventions: Rebif
Participants: 2
Sites: 1
Countries: Germany

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.